Kayashima, Michinori
Sakai, Kazuya
Harada, Kazuki
Kanetake, Jun
Kubo, Masayuki
Hamada, Eriko
Hayakawa, Masaki
Hatakeyama, Kinta
Matsumoto, Masanori http://orcid.org/0000-0002-7243-3126
Funding for this research was provided by:
the Ministry of Health, Labour, and Welfare of Japan
Article History
Received: 25 May 2021
Revised: 15 July 2021
Accepted: 16 July 2021
First Online: 22 July 2021
Declarations
:
: M. Matsumoto is a member of the clinical advisory board of Takeda Yakuhin and Sanofi. He is also an inventor of the ADAMTS13 act-ELISA. The remaining authors declare no competing financial interests.